Showing 1 - 8 of 8
The debate on whether insurance companies should be allowed to use results of individuals’ genetic tests for underwriting purposes has been both lively and increasingly relevant over the past two decades. Yet there appears to be no widely agreed upon resolution regarding appropriate and...
Persistent link: https://www.econbiz.de/10010552843
Guaranteed renewability is a prominent feature in many health and life insurance markets. It is well established in the literature that, when there is (only) risk type uncertainty, the optimal GR contract with renewal price set at the actuarially fair price for low risk types provides full...
Persistent link: https://www.econbiz.de/10011887363
Persistent link: https://www.econbiz.de/10009571566
Guaranteed renewability is a prominent feature in many health and life insurance markets. It is well established in the literature that, when there is (only) risk type uncertainty, the optimal GR contract with renewal price set at the actuarially fair price for low risk types provides full...
Persistent link: https://www.econbiz.de/10011864322
Basing insurance prices on the results of an imperfect screening test to identify risk types can reduce or increase aggregate discrimination across insureds. We present a powerful and general new framework of analysis to examine this issue, rawing upon recent work which uses decomposable...
Persistent link: https://www.econbiz.de/10005695877
The Weitzman Dismal Theorem (DT) suggests agents today should be willing to pay an unbounded amount to insure against fat-tailed risks of catastrophes such as climate change. The DT has been criticized for its assumption that marginal utility (MU) goes to negative infinite faster than the rate...
Persistent link: https://www.econbiz.de/10010535499
Persistent link: https://www.econbiz.de/10005526812
Persistent link: https://www.econbiz.de/10005729382